866-997-4948(US-Canada Toll Free)

Nanospectra Biosciences, Inc. - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 26 Pages


Nanospectra Biosciences, Inc. (Nanospectra) is a medical device company, based in the US. The company develops and commercializes particle-based therapies for the selective and precise thermal destruction of solid tumors. It provides AuroLase Therapy, a medical device that is applicable to the ablation of various solid tumors. The company also offers research-use-only nanoparticles with specific optical characteristics. It has an open investigational device exemption (IDE) to evaluate the safety and efficacy of aurolase therapy for the treatment of refractory head and neck cancers. The company was awarded SAIC contract for toxicity studies of Gold Nanorods. Nanospectra is headquartered in Houston, Texas, the US.

This report is a source for data, analysis and actionable intelligence on the Nanospectra Biosciences, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3

Key Facts 4
Nanospectra Biosciences, Inc. - Major Products and Services 5
Nanospectra Biosciences, Inc. Pipeline Products by Equipment Type 6
Nanospectra Biosciences, Inc. Pipeline Products by Development Stage 8
Nanospectra Biosciences, Inc. Pipeline Products by Therapy Area 10
Nanospectra Biosciences, Inc. Pipeline Products by Trial Phase 12
Aurolase System - Brain Tumor 14
Aurolase System - Brain Tumor Product Status 14
Aurolase System - Brain Tumor Product Description 14
Aurolase System - Lung Cancer 15
Aurolase System - Lung Cancer Product Status 15
Aurolase System - Lung Cancer Product Description 15
Aurolase System - Lung Cancer Clinical Trial 15
Aurolase System - Pancreatic Cancer 17
Aurolase System - Pancreatic Cancer Product Status 17
Aurolase System - Pancreatic Cancer Product Description 17
Aurolase System - Prostate Cancer 18
Aurolase System - Prostate Cancer Product Status 18
Aurolase System - Prostate Cancer Product Description 18
Aurolase System - Recurrent Head And Neck Cancer 19
Aurolase System - Recurrent Head And Neck Cancer Product Status 19
Aurolase System - Recurrent Head And Neck Cancer Product Description 19
Aurolase System - Recurrent Head And Neck Cancer Clinical Trial 19
Nanospectra Biosciences, Inc. - Key Competitors 22
Nanospectra Biosciences, Inc. - Key Employees 23
Nanospectra Biosciences, Inc. - Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Nanospectra Biosciences, Inc., Recent Developments 25
Aug 08, 2011: Nanospectra Appoints John Stroh As New CEO 25

Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Table


Nanospectra Biosciences, Inc., Key Facts 1
Nanospectra Biosciences, Inc. Key Pipeline Products by Equipment Type 1
Nanospectra Biosciences, Inc. Key Pipeline Products by Therapy Area 1
Nanospectra Biosciences, Inc. Key Pipeline Products by Development Stage 1
Nanospectra Biosciences, Inc. Key Pipeline Products by Trial Phase 1
Nanospectra Biosciences, Inc., Key Facts 4
Nanospectra Biosciences, Inc., Major Products and Services 5
Nanospectra Biosciences, Inc. Number of Pipeline Products by Equipment Type 6
Nanospectra Biosciences, Inc. Pipeline Products by Equipment Type 7
Nanospectra Biosciences, Inc. Number of Pipeline Products by Development Stage 8
Nanospectra Biosciences, Inc. Pipeline Products by Development Stage 9
Nanospectra Biosciences, Inc. Number of Pipeline Products by Therapy Area 10
Nanospectra Biosciences, Inc. Pipeline Products by Therapy Area 11
Nanospectra Biosciences, Inc. Number of Pipeline Products by Trial Phase 12
Nanospectra Biosciences, Inc. Pipeline Products by Trial Phase 13
Aurolase System - Brain Tumor - Product Status 14
Aurolase System - Brain Tumor - Product Description 14
Aurolase System - Lung Cancer - Product Status 15
Aurolase System - Lung Cancer - Product Description 15
Aurolase System - Lung Cancer - A Pilot Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors 15
Aurolase System - Pancreatic Cancer - Product Status 17
Aurolase System - Pancreatic Cancer - Product Description 17
Aurolase System - Prostate Cancer - Product Status 18
Aurolase System - Prostate Cancer - Product Description 18
Aurolase System - Recurrent Head And Neck Cancer - Product Status 19
Aurolase System - Recurrent Head And Neck Cancer - Product Description 19
Aurolase System - Recurrent Head And Neck Cancer - A Pilot Study of AuroLase Therapy in Patients With Refractory and/or Recurrent Tumors of the Head and Neck 19
Nanospectra Biosciences, Inc., Key Employees 23

List of Chart


Nanospectra Biosciences, Inc. Pipeline Products by Equipment Type 6
Nanospectra Biosciences, Inc. Pipeline Products by Development Stage 8
Nanospectra Biosciences, Inc. Pipeline Products by Therapy Area 10
Nanospectra Biosciences, Inc. Pipeline Products by Trial Phase 12

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *